Daniel Apple, MD
Ophthalmology · Detroit, MINPI 1649565045
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,940 of the $9,891 with a category attached, or 60.1%. Genentech USA, Inc. accounts for 78.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,660 and has fallen 93.4% since, to $502 in 2025. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $83.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$8K
- Regeneron Healthcare Solutions, Inc.$465
- AbbVie$331
- Bausch & Lomb Americas Inc.$257
- Apellis Pharmaceuticals, Inc.$216
- Oculus Surgical Inc.$171
- plus $651 from 6 others
Across 15 payments — averaging $947.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$14K
What the payments were for
- Consulting fees$5,94060%
- Travel & lodging$1,10911%
- Food & beverage$2,74228%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 29 | $7,801 |
| Regeneron Healthcare Solutions, Inc. | 22 | $465 |
| AbbVie(2 entities) | 17 | $331 |
| Bausch & Lomb Americas Inc. | 8 | $257 |
| Apellis Pharmaceuticals, Inc. | 11 | $216 |
| Oculus Surgical Inc. | 2 | $171 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $143 |
| Alimera Sciences, Inc. | 8 | $138 |
| Astellas Pharma US Inc | 5 | $134 |
| Alcon | 1 | $109 |
| Novartis | 4 | $67 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,891 in reported general payments places this provider in the 90th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 134 | $6,006 |
| ProlensaBromfenac Sodium | 11 | $4,495 |
| Ketorolac Tromethamine | 75 | $1,253 |
| Ofloxacin | 57 | $554 |
| Atropine Sulfate | 12 | $476 |
| Brimonidine Tartrate | 41 | $323 |
| ErythromycinErythromycin Base | 12 | $121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $143 | $4,49511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 674 ophthalmology providers in Michigan.
Other ophthalmology in Detroit
- Bret HughesDetroit$123K
- Pradeepa YoganathanDetroit$115K
- Michael ColemanDetroit$20K
- Daniel ZuckerbrodDetroit$16K
- Gabriel SosneDetroit$9K
- Manjool ShahAnn Arbor$609K
- Gregory KatzYpsilanti$401K
- Timothy PageBirmingham$250K
- David ZacksAnn Arbor$177K
- Scott WesthouseGrand Rapids$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.